US20200038089A1 - Tissue resection apparatus - Google Patents
Tissue resection apparatus Download PDFInfo
- Publication number
- US20200038089A1 US20200038089A1 US16/512,616 US201916512616A US2020038089A1 US 20200038089 A1 US20200038089 A1 US 20200038089A1 US 201916512616 A US201916512616 A US 201916512616A US 2020038089 A1 US2020038089 A1 US 2020038089A1
- Authority
- US
- United States
- Prior art keywords
- central tube
- coil
- tissue resection
- disposed
- tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002271 resection Methods 0.000 title claims abstract description 48
- 238000005520 cutting process Methods 0.000 claims abstract description 30
- 230000007246 mechanism Effects 0.000 claims description 15
- 230000037361 pathway Effects 0.000 claims description 15
- 238000002266 amputation Methods 0.000 claims description 11
- 238000004891 communication Methods 0.000 claims description 2
- 239000011295 pitch Substances 0.000 claims 6
- 239000012530 fluid Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 83
- 230000003902 lesion Effects 0.000 description 41
- 210000004072 lung Anatomy 0.000 description 32
- 238000000034 method Methods 0.000 description 31
- 206010028980 Neoplasm Diseases 0.000 description 29
- 201000011510 cancer Diseases 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 18
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 9
- 201000005202 lung cancer Diseases 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 208000020816 lung neoplasm Diseases 0.000 description 8
- 238000001574 biopsy Methods 0.000 description 6
- 238000002512 chemotherapy Methods 0.000 description 5
- 238000013188 needle biopsy Methods 0.000 description 5
- 241000208125 Nicotiana Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 210000000115 thoracic cavity Anatomy 0.000 description 4
- 210000000779 thoracic wall Anatomy 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004224 pleura Anatomy 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005773 cancer-related death Effects 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000004199 lung function Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 230000033616 DNA repair Effects 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 206010056342 Pulmonary mass Diseases 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000013275 image-guided biopsy Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 229910052704 radon Inorganic materials 0.000 description 1
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 208000017572 squamous cell neoplasm Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/32053—Punch like cutting instruments, e.g. using a cylindrical or oval knife
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/08—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
- A61B18/082—Probes or electrodes therefor
- A61B18/085—Forceps, scissors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/08—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
- A61B18/082—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
- A61B10/0266—Pointed or sharp biopsy instruments means for severing sample
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/04—Endoscopic instruments, e.g. catheter-type instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B17/07207—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously the staples being applied sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/32056—Surgical snare instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3209—Incision instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3403—Needle locating or guiding means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
- A61B17/3423—Access ports, e.g. toroid shape introducers for instruments or hands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12009—Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot
- A61B17/12013—Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot for use in minimally invasive surgery, e.g. endoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/04—Endoscopic instruments, e.g. catheter-type instruments
- A61B2010/045—Needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00809—Lung operations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B2017/320064—Surgical cutting instruments with tissue or sample retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00541—Lung or bronchi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00595—Cauterization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00601—Cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/126—Generators therefor characterised by the output polarity bipolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/142—Electrodes having a specific shape at least partly surrounding the target, e.g. concave, curved or in the form of a cave
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1435—Spiral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
Definitions
- the present invention relates to a system, device and method for tissue resection. More particularly, the present invention relates to a system, device and method for lesion removal.
- Cancer is not a single disease, but rather a collection of related diseases that can start essentially anywhere in the body.
- the body's cells begin to divide without stopping, proliferating and potentially spreading into surrounding tissues.
- cells grow and divide to form new cells as required by the body and when they become damaged or old, they die, and new cells replace the damaged or old cells; however, cancer interrupts this process.
- the cells become abnormal, and cells that should die do not and new cells form when they are not needed. These new cells can reproduce or proliferate without stopping and may form growths called tumors.
- Cancerous tumors are malignant, which means they can spread into or invade surrounding healthy tissue. In addition, cancer cells can break off and travel to remote areas in the body through blood or in the lymph system. Benign tumors, unlike malignant tumors, do not spread or invade surrounding tissue; however, they may grow large and cause damage. Both malignant and benign tumors may be removed or treated. Malignant tumors tend to grow back whereas benign tumors can grow back but are much less likely to do so.
- Cancer is a genetic disease in that it is caused by changes in the genes that control the ways that cells function, especially in how they grow and divide. Genetic changes that cause cancer may be inherited or they may arise over an individual's lifetime as a result of errors that occur as cells divide or because of damage to DNA caused by certain environmental exposure, for example, industrial/commercial chemicals and ultraviolet light.
- the genetic changes that may cause cancer tend to affect three types of genes; namely proto-oncogenes which are involved in normal cell growth and division, tumor suppressor genes which are also involved in controlling cell growth and division, and DNA repair genes which, as the name implies, are involved in repairing damaged DNA.
- the type of cancer may be named for the organ or tissue where the cancers arise, for example, lung cancer, or the type of cell that formed them, for example squamous cell cancer.
- Cancer is a leading cause of death both in the United States and world-wide. According to the World Health Organization, the number of new cancer cases will rise to twenty-five (25) million per year over the next two decades.
- Lung cancer is one of the most common cancers today. According to the World Cancer Report 2014 from the World Health Organization, lung cancer occurred in 14 million people and resulted in 8.8 million deaths world-wide, making it the most common cause of cancer-related death in men and the second most common cause of cancer-related death in women. Lung cancer or lung carcinoma is a malignant lung tumor that if left untreated can metastasize into neighboring tissues and organs. The majority of lung cancer is caused by long-term tobacco smoking; however, about 10 to 15 percent of lung cancer cases are not tobacco related. These non-tobacco cases are most often caused by a combination of genetic factors and exposure to certain environmental conditions, including radon gas, asbestos, second-hand tobacco smoke, other forms of air pollution, and other agents. The chance of surviving lung cancer as well as other forms of cancer depends on early detection and treatment.
- a biopsy is performed and sent for study. If it is determined that the lesion is cancerous, a second procedure may be performed to remove the cancer. If the biopsy reveals no cancer, it may be correct, or the biopsy did not pick the cancerous cells. Accordingly, there exists a need for removing the whole lesion in one single procedure so that an accurate diagnosis may be performed.
- the system, device and method for performing lung lesion removal of the present invention overcomes the limitations associated with the prior art.
- the present invention relates to a system, device and method for performing lung lesion removal.
- a lung needle biopsy is typically performed when an abnormality is found on an imaging test, for example, an X-ray or CAT scan.
- a fine needle is used to remove sample of lung tissue for examining under a microscope to determine the presence of abnormal cells.
- Tissue diagnosis is challenging in small ( ⁇ 6 mm) and intermediate (6-12 mm) nodules.
- CT guided biopsy of peripheral lesions either through the chest wall (80%) or by means of a bronchoscope (20%) yields only a 0.001-0.002 cm2 of diagnostic tissue, and as such, cancer, when present, is only successfully identified in 60% of small and intermediate nodules.
- bronchoscopic techniques and technology continue to evolve, biopsy accuracy, specificity, and sensitivity will always be limited when dealing with small and intermediate nodules in the periphery of the lung.
- a second procedure may be performed to remove the lesion and then followed up with chemotherapy and/or radiation.
- the second procedure most likely involves lung surgery. These procedures are typically done through an incision between the ribs. There are a number of possible procedures depending on the state of the cancer.
- Video-assisted thoracic surgery is a less invasive procedure for certain types of lung cancer. It is performed through small incisions utilizing an endoscopic approach and is typically utilized for performing wedge resections of smaller lesions close to the surface of a lung. In a wedge resection, a portion of the lobe is removed. In a sleeve resection, a portion of a large airway is removed thereby preserving more lung function.
- surgeons perform an open thoracotomy or lobectomy to remove lung nodules that are 2-3 cm from the lung surface.
- a thoracotomy is an open approach surgery in which a portion of a lobe, a full lobe or an entire lung is removed.
- a pneumonectomy an entire lung is removed. This type of surgery is obviously the most aggressive.
- a lobectomy an entire section or lobe of a lung is removed and represents a less aggressive approach than removing the entire lung. All thoracoscopic lung surgeries require trained and experienced thoracic surgeons and the favorability of surgical outcomes track with operative experience.
- any of these types of lung surgery is a major operation with possible complications which depend on the extent of the surgery as well as the patient's overall health.
- the recovery may take from weeks to months.
- a thoracotomy spreading of the ribs is required, thereby increasing postoperative pain.
- video-assisted thoracic surgery is less invasive, there can still be a substantial recovery period.
- full treatment may require a system chemotherapy and/or radiation treatment.
- a fine needle biopsy may not prove to be totally diagnostic.
- the fine needle biopsy procedure involves guiding a needle in three-dimensional space under two-dimensional imaging. Accordingly, the doctor may miss the lesion, or even if he or she hits the correct target, the section of the lesion that is removed through the needle may not contain the cancerous cells or the cells necessary to assess the aggressiveness of the tumor.
- a needle biopsy removes enough tissue to create a smear on a slide.
- the device of the present invention is designed to remove the entire lesion, or a substantial portion of it, while minimizing the amount of healthy lung tissue removal. This offers a number of advantages. Firstly, the entire lesion may be examined for a more accurate diagnosis without confounding sampling error, loss of cell packing or gross architecture. Secondly, since the entire lesion is removed, a secondary procedure as described above may not be required. Thirdly, localized chemotherapy and/or energy-based tumor extirpation, such as radiation, may be introduced via the cavity created by the lesion removal.
- the invention encompasses a tissue resection mechanism comprising an outer tube having a helical coil disposed on a distal end where the coil includes a first electrode.
- a central tube is provided having a distal edge profile including one or more surface segments, at least one of surface segments includes a second electrode.
- the central tube is slidably disposed within the outer tube and is position such that the second electrode opposes at least a portion the first electrode.
- a cutting tube includes a cutting edge slidably disposed within the central tube and the cutting tube is configured to advance at least as far as one of the coil segments.
- the invention encompasses a tissue resection mechanism comprising an outer tube having a helical coil disposed on a distal end where the coil includes a first electrode.
- a central tube is provided having a distal edge profile including one or more surface segments, at least one of surface segments includes a second electrode.
- the central tube is slidably disposed within the outer tube and is position such that the second electrode opposes at least a portion the first electrode.
- First and second ligating electrodes are disposed in the central tube and exposed to a central tube lumen.
- a snare is disposed in the central tube between the first and second ligating electrodes.
- a cutting tube includes a cutting edge slidably disposed within the central tube and the cutting tube is configured to advance at least as far as one of the coil segments.
- the invention encompasses a tissue resection mechanism comprising an outer tube having a helical coil disposed on a distal end where the coil includes a first electrode.
- a central tube is provided having a distal edge profile including one or more surface segments, at least one of surface segments includes a second electrode.
- the central tube is slidably disposed within the outer tube and is position such that the second electrode opposes at least a portion the first electrode.
- First and second ligating electrodes are disposed in the central tube and exposed to a central tube lumen.
- An amputation snare is disposed in the central tube and a ligation snare is disposed in the central tube.
- a cutting tube includes a cutting edge slidably disposed within the central tube and the cutting tube is configured to advance at least as far as one of the coil segments.
- FIG. 1 depicts a tissue resection device in accordance with an embodiment of the invention.
- FIG. 2 illustrates a sectional view of the tissue resection device of FIG. 1 .
- FIG. 3 shows a sectional view of a tissue resection device in accordance with an embodiment of the invention.
- FIG. 4 depicts a sectional view of a tissue resection device in accordance with an embodiment of the invention.
- FIG. 5 illustrates an exemplary anchor that may be employed in a lesion removal method in accordance with an embodiment of the invention.
- FIG. 6 shows a series of incision blades for use in a lesion removal method in accordance with an embodiment of the invention.
- FIG. 7 displays tissue dilators suitable for use in a lesion removal method in accordance with an embodiment of the invention.
- tissue resection device 1100 includes an outer tube 1105 is provided having a distal edge profile and having an inner diameter ID outer .
- a coil 1110 is attached to outer tube 1105 where the coil turns are spaced from and opposed to a distal end of outer tube 1105 .
- Coil 1110 preferably has a slightly blunted tip 1115 to minimize the possibility that it will penetrate through a blood vessel while being sufficiently sharp to penetrate tissue such as pleura and parenchyma.
- coil 1110 may take the form of a helix having a constant or variable pitch. Coil 1110 may also have a variable cross-sectional geometry.
- An electrode 1130 is disposed on a surface or embedded within coil 1110 .
- coil 1110 may include a plurality of contiguous coil segments, e.g., coil segments 1120 and 1125 .
- Coil segment 1120 comprises a helical member having a pitch of zero, e.g., a generally planar open ring structure, having an inner diameter ID coil and an outer diameter OD coil .
- Coil segment 1125 comprises a helical structure of constant or variable pitch and constant or variable cross-sectional geometry.
- electrode 1130 may be disposed on a surface of or embedded in coil segment 1120 .
- a central tube 1200 having a distal end with an edge profile comprising one or more surface segments and having an outer diameter OD central and an inner diameter ID central .
- an electrode 1205 is disposed on or embedded within at least one of the surface segments.
- Central tube 1200 is slidably disposed within outer tube 1105 and positioned such that electrode 1205 opposes and overlaps at least a portion of electrode 1130 .
- the space between electrode 1205 and electrode 1130 is referred to as the tissue clamping zone.
- OD central >ID coil and OD coil >ID central .
- OD central is about equal to OD coil . Accordingly, Central tube 1200 may be advanced through the tissue clamping zone towards coil 1110 such that electrode 1205 abuts electrode 1130 .
- a cutting tube 1300 is slidably disposed within central tube 1200 .
- the distal end of cutting tube 1300 is provided with a knife edge to facilitate tissue cutting.
- the resection device 1100 may be inserted into tissue and outer tube 1105 may be advanced a predetermined distance towards a target.
- Coil segment 1125 allows the device to penetrate the tissue in a manner similar to a cork screw. As coil segment 1125 penetrates tissue, any vessel in its path is either moved to planar coil segment 1120 or pushed away from the coil 1100 for subsequent turns. Coil tip 1115 is made blunt enough to minimize chances that it will penetrate through a blood vessel while still sharp enough to penetrate certain tissue such as the lung pleura and parenchyma.
- Central tube 1200 may then be advanced a predetermined distance towards the target. Any vessels that are disposed in the tissue clamping zone will be clamped between electrode 1130 and electrode 1205 .
- the vessels can then be sealed by the application of bipolar energy to electrode 1130 and electrode 1205 .
- cutting tube 1300 is advanced to core the tissue to the depth that outer tube 1105 has reached. The sealing and cutting process can be repeated to create a core of desired size.
- the resection device may be further configured to dissect a target lesion and seal tissue proximate the dissection point.
- central tube 1200 is provided with a ligation snare 1230 , first and second ligation electrodes 1215 and 1220 , an amputation snare 1225 and a ligation snare 1230 .
- the word “snare” refers to a flexible line, e.g., a string or a wire.
- the inner wall surface of central tube 1200 includes upper and lower circumferential grooved pathways 1212 and 1214 disposed proximate the distal end.
- the first and second ligation electrodes 1215 and 1220 are disposed on the inner wall of central tube 1200 such that lower circumferential groove 1214 is between them.
- Upper grooved pathway 1212 is disposed axially above ligation electrodes 1215 and 1220 .
- Ligation snare 1230 is disposed in lower circumferential groove 1214 and extends through central tube 1200 and axially along the outer wall surface to a snare activation mechanism (not shown).
- Amputation snare 1225 is disposed in upper circumferential groove 1212 and extends through central tube 1200 and axially along the outer wall surface to a snare activation mechanism (not shown).
- the outer surface of central tube 1200 may be provided with a plurality of axially extending grooved pathways which receive amputation snare 1225 , ligation snare 1230 and are in communication with upper and lower circumferential grooved pathways 1212 and 1214 .
- electrode leads for ligation electrodes 1215 and 1220 may extend to an energy source via the axially extending grooved pathways.
- the resection device of this embodiment can detach and seal the tissue core.
- Cutting tube 1300 may be retracted to expose ligation snare 1230 which is preferably made of flexible line, e.g., suture.
- Ligation snare 1230 may be engaged to snag tissue and pull tissue against the inner wall surface between first and second ligation electrodes 1215 and 1220 .
- Bipolar energy is then applied to first and second electrodes 1215 and 1220 to seal, i.e., cauterize, the tissue.
- cutting tube 1300 may be further retracted to expose amputation snare 1225 which may then be activated to sever the tissue core upstream from the point where the tissue was sealed (ligation point).
- amputation snare 1225 has a smaller diameter than that of ligation snare 1230 .
- the smaller diameter facilitates tissue slicing. Accordingly, the resection device 1100 according to this embodiment both creates a tissue core and disengages the core from surrounding tissue.
- the resection device of the invention is provided with a single snare disposed between ligation electrodes which both ligates and cuts tissue.
- the single snare first pulls tissue against the inner wall surface of central tube 1200 between ligation electrodes 1215 and 1220 .
- Bipolar energy is then applied to first and second electrodes 1215 and 1220 to seal, i.e., cauterize, the tissue. Once sealed, the snare is further pulled to sever the tissue core.
- ligation snare 1230 includes a set of knots 1235 and 1240 which tighten under load, shown, for example, in FIG. 4 .
- Ligation is performed by retracting cutting tube 1300 to expose ligation snare 1210 and activating ligation snare 1230 which lassos tissue as ligation knot tightens. Once the tissue is lassoed, cutting tube 1300 may be further retracted to expose amputation snare 1225 which may then be activated to sever the tissue core upstream from the point where the point where the tissue was lassoed.
- the present invention also contemplates a method and system for using the resection device to remove tissue lesions, for example, lung lesions.
- the method generally comprises anchoring the lesion targeted for removal, creating a channel in the tissue leading to the target lesion, creating a tissue core which includes the anchored lesion, ligating the tissue core and sealing the surrounding tissue, and removing the tissue core including the target lesion from the channel.
- Anchoring may be performed by, any suitable structure for securing the device to the lung.
- a channel may be created to facilitate insertion of resection device 1100 .
- the channel may be created by making an incision in the lung area and inserting a tissue dilator and port into the incision.
- a tissue core which includes the anchored lesion may be created.
- resection device 1100 may be inserted into the channel and used to create the tissue core, to ligate the tissue core and to seal the tissue core and sever it from the surrounding tissue as described hereinabove.
- the tissue core may then be removed from the channel.
- a cavity port may be inserted in the channel to facilitate subsequent treatment of the target lesion site through chemotherapy and/or energy-based tumor extirpation such as radiation.
- the anchor depicted in FIG. 5 is suitable for use in performing the method for removing tissue lesions described herein.
- the anchor comprises an outer tube 1422 having a sufficiently sharp edge to pierce the chest cavity tissue and lung without causing excess damage and an inner tube 1424 disposed within outer tube 1422 .
- One or more tines or fingers 1426 formed from shape memory material, e.g., Nitinol, preformed are attached to the end of inner tube 1424 .
- Outer tube 1422 is retractably disposed over inner tube 1424 such that when outer tube 1422 is retracted, tines 1426 assume their preform shape as shown. In keeping with the invention, outer tube 1422 is retracted after it has pierced the lung lesion thereby causing tines 1426 to engage the lung lesion.
- Other suitable anchors may include coils and suction-based structures.
- the incision blades depicted in FIG. 6 are suitable for use in performing the method for removing tissue lesions described herein.
- anchor 1400 it is preferable to create a small cut or incision to facilitate insertion of chest wall tissue dilator.
- Incision blades 1605 are used to make a wider cut.
- Successive incision blades 1605 include a central aperture which allows them to be coaxially advanced along the anchor needle 1405 to create a wider cut in the chest wall, with each successive blade being larger than the previous blade, thereby increasing the width of the incision.
- the tissue dilator depicted in FIG. 7 is suitable for use in performing the method for removing tissue lesions described herein.
- the tissue dilator may comprise any suitable device for creating a channel in organic tissue.
- the tissue dilator assembly includes a single cylindrical rod with rounded end 1510 or a cylindrical rod with rounded end and a rigid sleeve arrangement 1515 .
- Successive tissue dilators are coaxially advanced along the anchor needle to create tissue tract or channel in the chest wall, with each successive dilator being larger than the previous dilator, thereby increasing the diameter of the channel.
- the inner rod 1505 is removed while leaving the rigid sleeve in the intercoastal space between ribs to create direct passage to the lung pleura.
- tissue resection device capable of penetrating lung tissue and creating a tissue core including a target lesion is suitable for use in performing the method for removing tissue lesions described herein.
- Tissue resection device 1100 described hereinbefore is preferred.
- tissue resection device 1100 Once tissue resection device 1100 is removed, a small channel in the lung exits where the target lesion was removed.
- This channel may be utilized to introduce an energy-based ablation device and/or localized chemotherapy depending on the results of the tissue diagnosis. Accordingly, the method and system of the present invention may not only be utilized to ensure an effective biopsy is performed but also complete removal of the lesion with minimal healthy lung tissue removal.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Otolaryngology (AREA)
- Plasma & Fusion (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This application claims priority from application Ser. No. 62/712,545 filed Jul. 31, 2018, which is incorporated herein by reference in its entirety.
- This application claims priority from application Ser. No. 62/728,170 filed Sep. 7, 2018, which is incorporated herein by reference in its entirety.
- This application claims priority from application Ser. No. 62/744,797 filed Oct. 12, 2018, which is incorporated herein by reference in its entirety.
- This application claims priority from application Ser. No. 62/749,302 filed Oct. 23, 2018, which is incorporated herein by reference in its entirety.
- This application claims priority from application Ser. No. 62/756,234 filed Nov. 6, 2018, which is incorporated herein by reference in its entirety.
- The present invention relates to a system, device and method for tissue resection. More particularly, the present invention relates to a system, device and method for lesion removal.
- Cancer is not a single disease, but rather a collection of related diseases that can start essentially anywhere in the body. Common amongst all types of cancer is that the body's cells begin to divide without stopping, proliferating and potentially spreading into surrounding tissues. In the normal course of events, cells grow and divide to form new cells as required by the body and when they become damaged or old, they die, and new cells replace the damaged or old cells; however, cancer interrupts this process. With cancer, the cells become abnormal, and cells that should die do not and new cells form when they are not needed. These new cells can reproduce or proliferate without stopping and may form growths called tumors.
- Cancerous tumors are malignant, which means they can spread into or invade surrounding healthy tissue. In addition, cancer cells can break off and travel to remote areas in the body through blood or in the lymph system. Benign tumors, unlike malignant tumors, do not spread or invade surrounding tissue; however, they may grow large and cause damage. Both malignant and benign tumors may be removed or treated. Malignant tumors tend to grow back whereas benign tumors can grow back but are much less likely to do so.
- Cancer is a genetic disease in that it is caused by changes in the genes that control the ways that cells function, especially in how they grow and divide. Genetic changes that cause cancer may be inherited or they may arise over an individual's lifetime as a result of errors that occur as cells divide or because of damage to DNA caused by certain environmental exposure, for example, industrial/commercial chemicals and ultraviolet light. The genetic changes that may cause cancer tend to affect three types of genes; namely proto-oncogenes which are involved in normal cell growth and division, tumor suppressor genes which are also involved in controlling cell growth and division, and DNA repair genes which, as the name implies, are involved in repairing damaged DNA.
- More than one-hundred distinct types of cancer have been identified. The type of cancer may be named for the organ or tissue where the cancers arise, for example, lung cancer, or the type of cell that formed them, for example squamous cell cancer. Cancer, unfortunately, is a leading cause of death both in the United States and world-wide. According to the World Health Organization, the number of new cancer cases will rise to twenty-five (25) million per year over the next two decades.
- Lung cancer is one of the most common cancers today. According to the World Cancer Report 2014 from the World Health Organization, lung cancer occurred in 14 million people and resulted in 8.8 million deaths world-wide, making it the most common cause of cancer-related death in men and the second most common cause of cancer-related death in women. Lung cancer or lung carcinoma is a malignant lung tumor that if left untreated can metastasize into neighboring tissues and organs. The majority of lung cancer is caused by long-term tobacco smoking; however, about 10 to 15 percent of lung cancer cases are not tobacco related. These non-tobacco cases are most often caused by a combination of genetic factors and exposure to certain environmental conditions, including radon gas, asbestos, second-hand tobacco smoke, other forms of air pollution, and other agents. The chance of surviving lung cancer as well as other forms of cancer depends on early detection and treatment.
- When a lesion is detected in the lungs, a biopsy is performed and sent for study. If it is determined that the lesion is cancerous, a second procedure may be performed to remove the cancer. If the biopsy reveals no cancer, it may be correct, or the biopsy did not pick the cancerous cells. Accordingly, there exists a need for removing the whole lesion in one single procedure so that an accurate diagnosis may be performed.
- The system, device and method for performing lung lesion removal of the present invention overcomes the limitations associated with the prior art.
- The present invention relates to a system, device and method for performing lung lesion removal. A lung needle biopsy is typically performed when an abnormality is found on an imaging test, for example, an X-ray or CAT scan. In a lung needle biopsy, a fine needle is used to remove sample of lung tissue for examining under a microscope to determine the presence of abnormal cells. Tissue diagnosis is challenging in small (<6 mm) and intermediate (6-12 mm) nodules. CT guided biopsy of peripheral lesions, either through the chest wall (80%) or by means of a bronchoscope (20%) yields only a 0.001-0.002 cm2 of diagnostic tissue, and as such, cancer, when present, is only successfully identified in 60% of small and intermediate nodules. Although bronchoscopic techniques and technology continue to evolve, biopsy accuracy, specificity, and sensitivity will always be limited when dealing with small and intermediate nodules in the periphery of the lung.
- If it is determined that the lesion is cancerous, a second procedure may be performed to remove the lesion and then followed up with chemotherapy and/or radiation. The second procedure most likely involves lung surgery. These procedures are typically done through an incision between the ribs. There are a number of possible procedures depending on the state of the cancer. Video-assisted thoracic surgery is a less invasive procedure for certain types of lung cancer. It is performed through small incisions utilizing an endoscopic approach and is typically utilized for performing wedge resections of smaller lesions close to the surface of a lung. In a wedge resection, a portion of the lobe is removed. In a sleeve resection, a portion of a large airway is removed thereby preserving more lung function.
- Nodules deeper than 2-3 cm from the lung surface, once identified as suspicious for cancer, are difficult to localize and excise using laparoscopic or robotic lung sparing technique despite pre-procedure image guided biopsy and localization. Thus, surgeons perform an open thoracotomy or lobectomy to remove lung nodules that are 2-3 cm from the lung surface. A thoracotomy is an open approach surgery in which a portion of a lobe, a full lobe or an entire lung is removed. In a pneumonectomy, an entire lung is removed. This type of surgery is obviously the most aggressive. In a lobectomy, an entire section or lobe of a lung is removed and represents a less aggressive approach than removing the entire lung. All thoracoscopic lung surgeries require trained and experienced thoracic surgeons and the favorability of surgical outcomes track with operative experience.
- Any of these types of lung surgery is a major operation with possible complications which depend on the extent of the surgery as well as the patient's overall health. In addition to the reduction in lung function associated with any of these procedures, the recovery may take from weeks to months. With a thoracotomy, spreading of the ribs is required, thereby increasing postoperative pain. Although video-assisted thoracic surgery is less invasive, there can still be a substantial recovery period. In addition, once the surgery is complete, full treatment may require a system chemotherapy and/or radiation treatment.
- As set forth above, a fine needle biopsy may not prove to be totally diagnostic. The fine needle biopsy procedure involves guiding a needle in three-dimensional space under two-dimensional imaging. Accordingly, the doctor may miss the lesion, or even if he or she hits the correct target, the section of the lesion that is removed through the needle may not contain the cancerous cells or the cells necessary to assess the aggressiveness of the tumor. A needle biopsy removes enough tissue to create a smear on a slide. The device of the present invention is designed to remove the entire lesion, or a substantial portion of it, while minimizing the amount of healthy lung tissue removal. This offers a number of advantages. Firstly, the entire lesion may be examined for a more accurate diagnosis without confounding sampling error, loss of cell packing or gross architecture. Secondly, since the entire lesion is removed, a secondary procedure as described above may not be required. Thirdly, localized chemotherapy and/or energy-based tumor extirpation, such as radiation, may be introduced via the cavity created by the lesion removal.
- In at least one embodiment, the invention encompasses a tissue resection mechanism comprising an outer tube having a helical coil disposed on a distal end where the coil includes a first electrode. A central tube is provided having a distal edge profile including one or more surface segments, at least one of surface segments includes a second electrode. The central tube is slidably disposed within the outer tube and is position such that the second electrode opposes at least a portion the first electrode. A cutting tube includes a cutting edge slidably disposed within the central tube and the cutting tube is configured to advance at least as far as one of the coil segments.
- In another embodiment the invention encompasses a tissue resection mechanism comprising an outer tube having a helical coil disposed on a distal end where the coil includes a first electrode. A central tube is provided having a distal edge profile including one or more surface segments, at least one of surface segments includes a second electrode. The central tube is slidably disposed within the outer tube and is position such that the second electrode opposes at least a portion the first electrode. First and second ligating electrodes are disposed in the central tube and exposed to a central tube lumen. A snare is disposed in the central tube between the first and second ligating electrodes. A cutting tube includes a cutting edge slidably disposed within the central tube and the cutting tube is configured to advance at least as far as one of the coil segments.
- In still another embodiment the invention encompasses a tissue resection mechanism comprising an outer tube having a helical coil disposed on a distal end where the coil includes a first electrode. A central tube is provided having a distal edge profile including one or more surface segments, at least one of surface segments includes a second electrode. The central tube is slidably disposed within the outer tube and is position such that the second electrode opposes at least a portion the first electrode. First and second ligating electrodes are disposed in the central tube and exposed to a central tube lumen. An amputation snare is disposed in the central tube and a ligation snare is disposed in the central tube. A cutting tube includes a cutting edge slidably disposed within the central tube and the cutting tube is configured to advance at least as far as one of the coil segments.
- The foregoing and other features and advantages of the invention will be apparent from the following, more particular description of preferred embodiments of the invention, as illustrated in the accompanying drawings.
-
FIG. 1 depicts a tissue resection device in accordance with an embodiment of the invention. -
FIG. 2 illustrates a sectional view of the tissue resection device ofFIG. 1 . -
FIG. 3 shows a sectional view of a tissue resection device in accordance with an embodiment of the invention. -
FIG. 4 depicts a sectional view of a tissue resection device in accordance with an embodiment of the invention. -
FIG. 5 illustrates an exemplary anchor that may be employed in a lesion removal method in accordance with an embodiment of the invention. -
FIG. 6 shows a series of incision blades for use in a lesion removal method in accordance with an embodiment of the invention. -
FIG. 7 displays tissue dilators suitable for use in a lesion removal method in accordance with an embodiment of the invention. - The resection device of the present invention comprises an energy-based arrangement capable of penetrating tissue towards a target lesion. In one embodiment depicted in
FIG. 1 ,tissue resection device 1100 includes anouter tube 1105 is provided having a distal edge profile and having an inner diameter IDouter. Acoil 1110 is attached toouter tube 1105 where the coil turns are spaced from and opposed to a distal end ofouter tube 1105.Coil 1110 preferably has a slightly bluntedtip 1115 to minimize the possibility that it will penetrate through a blood vessel while being sufficiently sharp to penetrate tissue such as pleura and parenchyma. In some embodiments,coil 1110 may take the form of a helix having a constant or variable pitch.Coil 1110 may also have a variable cross-sectional geometry. Anelectrode 1130 is disposed on a surface or embedded withincoil 1110. - In some embodiments, as illustrated in
FIG. 1 ,coil 1110 may include a plurality of contiguous coil segments, e.g.,coil segments Coil segment 1120 comprises a helical member having a pitch of zero, e.g., a generally planar open ring structure, having an inner diameter IDcoil and an outer diameter ODcoil.Coil segment 1125 comprises a helical structure of constant or variable pitch and constant or variable cross-sectional geometry. In this embodiment,electrode 1130 may be disposed on a surface of or embedded incoil segment 1120. - A
central tube 1200 is provided having a distal end with an edge profile comprising one or more surface segments and having an outer diameter ODcentral and an inner diameter IDcentral. As illustrated inFIG. 2 , anelectrode 1205 is disposed on or embedded within at least one of the surface segments.Central tube 1200 is slidably disposed withinouter tube 1105 and positioned such thatelectrode 1205 opposes and overlaps at least a portion ofelectrode 1130. The space betweenelectrode 1205 andelectrode 1130 is referred to as the tissue clamping zone. In keeping with an aspect of the invention, ODcentral>IDcoil and ODcoil>IDcentral. In some embodiments, ODcentral is about equal to ODcoil. Accordingly,Central tube 1200 may be advanced through the tissue clamping zone towardscoil 1110 such thatelectrode 1205 abutselectrode 1130. - A cutting
tube 1300 is slidably disposed withincentral tube 1200. The distal end of cuttingtube 1300 is provided with a knife edge to facilitate tissue cutting. - To enable tissue resection, the
resection device 1100 may be inserted into tissue andouter tube 1105 may be advanced a predetermined distance towards a target.Coil segment 1125 allows the device to penetrate the tissue in a manner similar to a cork screw. Ascoil segment 1125 penetrates tissue, any vessel in its path is either moved toplanar coil segment 1120 or pushed away from thecoil 1100 for subsequent turns.Coil tip 1115 is made blunt enough to minimize chances that it will penetrate through a blood vessel while still sharp enough to penetrate certain tissue such as the lung pleura and parenchyma.Central tube 1200 may then be advanced a predetermined distance towards the target. Any vessels that are disposed in the tissue clamping zone will be clamped betweenelectrode 1130 andelectrode 1205. The vessels can then be sealed by the application of bipolar energy toelectrode 1130 andelectrode 1205. Once blood vessels are sealed, cuttingtube 1300 is advanced to core the tissue to the depth thatouter tube 1105 has reached. The sealing and cutting process can be repeated to create a core of desired size. - In keeping with an aspect of the invention, the resection device may be further configured to dissect a target lesion and seal tissue proximate the dissection point. To facilitate dissection and sealing, as illustrated in
FIG. 3 ,central tube 1200 is provided with aligation snare 1230, first andsecond ligation electrodes amputation snare 1225 and aligation snare 1230. As used herein, the word “snare” refers to a flexible line, e.g., a string or a wire. The inner wall surface ofcentral tube 1200 includes upper and lower circumferentialgrooved pathways second ligation electrodes central tube 1200 such that lowercircumferential groove 1214 is between them. Uppergrooved pathway 1212 is disposed axially aboveligation electrodes -
Ligation snare 1230 is disposed in lowercircumferential groove 1214 and extends throughcentral tube 1200 and axially along the outer wall surface to a snare activation mechanism (not shown).Amputation snare 1225 is disposed in uppercircumferential groove 1212 and extends throughcentral tube 1200 and axially along the outer wall surface to a snare activation mechanism (not shown). The outer surface ofcentral tube 1200 may be provided with a plurality of axially extending grooved pathways which receiveamputation snare 1225,ligation snare 1230 and are in communication with upper and lower circumferentialgrooved pathways ligation electrodes - In operation, the resection device of this embodiment can detach and seal the tissue core. Cutting
tube 1300 may be retracted to exposeligation snare 1230 which is preferably made of flexible line, e.g., suture.Ligation snare 1230 may be engaged to snag tissue and pull tissue against the inner wall surface between first andsecond ligation electrodes second electrodes tube 1300 may be further retracted to exposeamputation snare 1225 which may then be activated to sever the tissue core upstream from the point where the tissue was sealed (ligation point). In some embodiments,amputation snare 1225 has a smaller diameter than that ofligation snare 1230. The smaller diameter facilitates tissue slicing. Accordingly, theresection device 1100 according to this embodiment both creates a tissue core and disengages the core from surrounding tissue. - In an alternative embodiment, the resection device of the invention is provided with a single snare disposed between ligation electrodes which both ligates and cuts tissue. In this embodiment, the single snare first pulls tissue against the inner wall surface of
central tube 1200 betweenligation electrodes second electrodes - In yet another embodiment, cutting and sealing may be performed without employing electrodes. In this embodiment,
ligation snare 1230 includes a set ofknots FIG. 4 . Ligation is performed by retractingcutting tube 1300 to expose ligation snare 1210 and activatingligation snare 1230 which lassos tissue as ligation knot tightens. Once the tissue is lassoed, cuttingtube 1300 may be further retracted to exposeamputation snare 1225 which may then be activated to sever the tissue core upstream from the point where the point where the tissue was lassoed. - The present invention also contemplates a method and system for using the resection device to remove tissue lesions, for example, lung lesions. The method generally comprises anchoring the lesion targeted for removal, creating a channel in the tissue leading to the target lesion, creating a tissue core which includes the anchored lesion, ligating the tissue core and sealing the surrounding tissue, and removing the tissue core including the target lesion from the channel.
- Anchoring may be performed by, any suitable structure for securing the device to the lung. Once the lesion is anchored, a channel may be created to facilitate insertion of
resection device 1100. The channel may be created by making an incision in the lung area and inserting a tissue dilator and port into the incision. A tissue core which includes the anchored lesion may be created. In keeping with the invention,resection device 1100 may be inserted into the channel and used to create the tissue core, to ligate the tissue core and to seal the tissue core and sever it from the surrounding tissue as described hereinabove. The tissue core may then be removed from the channel. In keeping with the invention, a cavity port may be inserted in the channel to facilitate subsequent treatment of the target lesion site through chemotherapy and/or energy-based tumor extirpation such as radiation. - The anchor depicted in
FIG. 5 is suitable for use in performing the method for removing tissue lesions described herein. The anchor comprises anouter tube 1422 having a sufficiently sharp edge to pierce the chest cavity tissue and lung without causing excess damage and aninner tube 1424 disposed withinouter tube 1422. One or more tines or fingers 1426 formed from shape memory material, e.g., Nitinol, preformed are attached to the end ofinner tube 1424.Outer tube 1422 is retractably disposed overinner tube 1424 such that whenouter tube 1422 is retracted, tines 1426 assume their preform shape as shown. In keeping with the invention,outer tube 1422 is retracted after it has pierced the lung lesion thereby causing tines 1426 to engage the lung lesion. Other suitable anchors may include coils and suction-based structures. - The incision blades depicted in
FIG. 6 are suitable for use in performing the method for removing tissue lesions described herein. Once anchor 1400 is set, it is preferable to create a small cut or incision to facilitate insertion of chest wall tissue dilator.Incision blades 1605 are used to make a wider cut.Successive incision blades 1605 include a central aperture which allows them to be coaxially advanced along the anchor needle 1405 to create a wider cut in the chest wall, with each successive blade being larger than the previous blade, thereby increasing the width of the incision. - The tissue dilator depicted in
FIG. 7 is suitable for use in performing the method for removing tissue lesions described herein. The tissue dilator may comprise any suitable device for creating a channel in organic tissue. In one exemplary embodiment, the tissue dilator assembly includes a single cylindrical rod withrounded end 1510 or a cylindrical rod with rounded end and arigid sleeve arrangement 1515. Successive tissue dilators are coaxially advanced along the anchor needle to create tissue tract or channel in the chest wall, with each successive dilator being larger than the previous dilator, thereby increasing the diameter of the channel. Once the final dilator with rigid sleeve is deployed, the inner rod 1505 is removed while leaving the rigid sleeve in the intercoastal space between ribs to create direct passage to the lung pleura. - Any tissue resection device capable of penetrating lung tissue and creating a tissue core including a target lesion is suitable for use in performing the method for removing tissue lesions described herein.
Tissue resection device 1100 described hereinbefore is preferred. - Once
tissue resection device 1100 is removed, a small channel in the lung exits where the target lesion was removed. This channel may be utilized to introduce an energy-based ablation device and/or localized chemotherapy depending on the results of the tissue diagnosis. Accordingly, the method and system of the present invention may not only be utilized to ensure an effective biopsy is performed but also complete removal of the lesion with minimal healthy lung tissue removal. - Although shown and described is what is believed to be the most practical and preferred embodiments, it is apparent that departures from specific designs and methods described and shown will suggest themselves to those skilled in the art and may be used without departing from the spirit and scope of the invention. For example, the systems, devices and methods described herein for removal of lesions from the lung. It will be appreciated by the skilled artisan that the devices and methods described herein may are not limited to the lung and could be used for tissue resection and lesion removal in other areas of the body. The present invention is not restricted to the particular constructions described and illustrated, but should be constructed to cohere with all modifications that may fall within the scope of the appended claims.
Claims (20)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/512,616 US20200038089A1 (en) | 2018-07-31 | 2019-07-16 | Tissue resection apparatus |
PL19189128T PL3603545T3 (en) | 2018-07-31 | 2019-07-30 | Tissue resection apparatus |
EP19189128.2A EP3603545B1 (en) | 2018-07-31 | 2019-07-30 | Tissue resection apparatus |
BR102019015646A BR102019015646A2 (en) | 2018-07-31 | 2019-07-30 | tissue resection apparatus |
ES19189128T ES2870804T3 (en) | 2018-07-31 | 2019-07-30 | Tissue resection equipment |
JP2019139478A JP7481096B2 (en) | 2018-07-31 | 2019-07-30 | Tissue Resection Device |
CN201910701397.XA CN110772313A (en) | 2018-07-31 | 2019-07-31 | Tissue resection device |
US17/226,738 US20210219967A1 (en) | 2019-07-16 | 2021-04-09 | Systems, devices, and methods for coring tissue |
US18/335,975 US12102372B2 (en) | 2018-07-31 | 2023-06-15 | Tissue resection apparatus |
JP2024071473A JP2024087050A (en) | 2018-07-31 | 2024-04-25 | Tissue resection apparatus |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862712545P | 2018-07-31 | 2018-07-31 | |
US201862728170P | 2018-09-07 | 2018-09-07 | |
US201862744797P | 2018-10-12 | 2018-10-12 | |
US201862749302P | 2018-10-23 | 2018-10-23 | |
US201862756234P | 2018-11-06 | 2018-11-06 | |
US16/512,616 US20200038089A1 (en) | 2018-07-31 | 2019-07-16 | Tissue resection apparatus |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/512,628 Continuation-In-Part US11723708B2 (en) | 2018-07-31 | 2019-07-16 | Method for removing a tissue lesion |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/226,738 Continuation-In-Part US20210219967A1 (en) | 2019-07-16 | 2021-04-09 | Systems, devices, and methods for coring tissue |
US18/335,975 Continuation US12102372B2 (en) | 2018-07-31 | 2023-06-15 | Tissue resection apparatus |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200038089A1 true US20200038089A1 (en) | 2020-02-06 |
Family
ID=67513396
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/512,616 Abandoned US20200038089A1 (en) | 2018-07-31 | 2019-07-16 | Tissue resection apparatus |
US18/335,975 Active US12102372B2 (en) | 2018-07-31 | 2023-06-15 | Tissue resection apparatus |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/335,975 Active US12102372B2 (en) | 2018-07-31 | 2023-06-15 | Tissue resection apparatus |
Country Status (7)
Country | Link |
---|---|
US (2) | US20200038089A1 (en) |
EP (1) | EP3603545B1 (en) |
JP (2) | JP7481096B2 (en) |
CN (1) | CN110772313A (en) |
BR (1) | BR102019015646A2 (en) |
ES (1) | ES2870804T3 (en) |
PL (1) | PL3603545T3 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210338265A1 (en) * | 2020-04-30 | 2021-11-04 | Ethicon, Inc. | Methods and devices for delivering cancer therapy to a target tissue site via a cored tissue cavity |
US20210393332A1 (en) * | 2020-06-22 | 2021-12-23 | Ethicon, Inc. | Methods and devices for navigating a tissue resection device |
WO2022038433A1 (en) * | 2020-08-17 | 2022-02-24 | Ethicon, Inc. | Coring and amputation devices, systems, and methods |
US12102372B2 (en) | 2018-07-31 | 2024-10-01 | Prana Thoracic, Inc. | Tissue resection apparatus |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040254572A1 (en) * | 2003-04-25 | 2004-12-16 | Mcintyre Jon T. | Self anchoring radio frequency ablation array |
US20070179494A1 (en) * | 2003-05-16 | 2007-08-02 | Andre Faure | Medical device using a coiled electrode |
US20120071922A1 (en) * | 2010-09-20 | 2012-03-22 | Shanley John F | System for providing surgical access |
US9895190B2 (en) * | 2014-04-28 | 2018-02-20 | Warsaw Orthopedic, Inc. | Devices and methods for radiofrequency ablation having at least two electrodes |
Family Cites Families (132)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4007732A (en) | 1975-09-02 | 1977-02-15 | Robert Carl Kvavle | Method for location and removal of soft tissue in human biopsy operations |
US4735194C1 (en) | 1987-01-13 | 2001-05-08 | Dept Of Veterans Affairs The U | Flexile endoscopic ligating instrument |
US5779698A (en) | 1989-01-18 | 1998-07-14 | Applied Medical Resources Corporation | Angioplasty catheter system and method for making same |
US5196024A (en) | 1990-07-03 | 1993-03-23 | Cedars-Sinai Medical Center | Balloon catheter with cutting edge |
US5353804A (en) | 1990-09-18 | 1994-10-11 | Peb Biopsy Corporation | Method and device for percutaneous exisional breast biopsy |
US5190561A (en) | 1991-01-23 | 1993-03-02 | Surgical Innovations, Inc. | Tissue and organ extractor |
US5133360A (en) | 1991-03-07 | 1992-07-28 | Spears Colin P | Spears retriever |
US5810811A (en) | 1993-07-22 | 1998-09-22 | Ethicon Endo-Surgery, Inc. | Electrosurgical hemostatic device |
US5507743A (en) | 1993-11-08 | 1996-04-16 | Zomed International | Coiled RF electrode treatment apparatus |
CA2195948A1 (en) | 1994-07-25 | 1996-02-08 | Tai C. Cheng | Composite polyester material having a lubricous surface |
US5643282A (en) | 1994-08-22 | 1997-07-01 | Kieturakis; Maciej J. | Surgical instrument and method for removing tissue from an endoscopic workspace |
EP0818975B1 (en) | 1995-03-31 | 2004-07-14 | Boston Scientific Limited | Biopsy sampler |
US5651788A (en) | 1995-05-17 | 1997-07-29 | C.R. Bard, Inc. | Mucosectomy process and device |
US5746716A (en) | 1995-07-10 | 1998-05-05 | Interventional Technologies Inc. | Catheter for injecting fluid medication into an arterial wall |
US5817034A (en) | 1995-09-08 | 1998-10-06 | United States Surgical Corporation | Apparatus and method for removing tissue |
US5882316A (en) | 1996-08-29 | 1999-03-16 | City Of Hope | Minimally invasive biopsy device |
CA2209366C (en) | 1996-09-13 | 2004-11-02 | Interventional Technologies, Inc. | Incisor-dilator with tapered balloon |
JP3287788B2 (en) | 1996-10-07 | 2002-06-04 | 株式会社脳機能研究所 | EEG measurement headgear |
US7083613B2 (en) | 1997-03-05 | 2006-08-01 | The Trustees Of Columbia University In The City Of New York | Ringed forceps |
US5843108A (en) | 1997-10-23 | 1998-12-01 | Samuels; Shaun Laurence Wilkie | Over the wire scapel |
US5908435A (en) | 1997-10-23 | 1999-06-01 | Samuels; Shaun L. W. | Expandable lumen device and method of use |
US6602204B2 (en) | 1998-02-10 | 2003-08-05 | Artemis Medical, Inc | Intraoperative tissue treatment methods |
US20040010206A1 (en) | 1998-02-10 | 2004-01-15 | Dubrul William R. | Intraoperative tissue treatment methods |
AU9326398A (en) | 1997-11-24 | 1999-06-10 | Johnson & Johnson Research Pty. Limited | Biopsy assembly including an expandable sleeve |
EP0923907A1 (en) * | 1997-12-19 | 1999-06-23 | Gyrus Medical Limited | An electrosurgical instrument |
US5961526A (en) | 1998-02-18 | 1999-10-05 | Boston Scientific Corporation | Coaxial needle and severing snare |
US6493589B1 (en) | 1998-05-07 | 2002-12-10 | Medtronic, Inc. | Methods and apparatus for treatment of pulmonary conditions |
US7198635B2 (en) | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US6022362A (en) | 1998-09-03 | 2000-02-08 | Rubicor Medical, Inc. | Excisional biopsy devices and methods |
US6569173B1 (en) | 1999-12-14 | 2003-05-27 | Integrated Vascular Interventional Technologies, L.C. | Compression plate anastomosis apparatus |
US6699256B1 (en) | 1999-06-04 | 2004-03-02 | St. Jude Medical Atg, Inc. | Medical grafting apparatus and methods |
US6306132B1 (en) | 1999-06-17 | 2001-10-23 | Vivant Medical | Modular biopsy and microwave ablation needle delivery apparatus adapted to in situ assembly and method of use |
WO2001019232A2 (en) | 1999-09-14 | 2001-03-22 | Papillon Surgical | Over the wire breast biopsy system |
US20040215296A1 (en) | 1999-11-16 | 2004-10-28 | Barrx, Inc. | System and method for treating abnormal epithelium in an esophagus |
US6197042B1 (en) | 2000-01-05 | 2001-03-06 | Medical Technology Group, Inc. | Vascular sheath with puncture site closure apparatus and methods of use |
US6517477B1 (en) | 2000-01-27 | 2003-02-11 | Scimed Life Systems, Inc. | Catheter introducer system for exploration of body cavities |
WO2001060235A2 (en) | 2000-02-18 | 2001-08-23 | Fogarty Thomas J M D | Improved device for accurately marking tissue |
US6770070B1 (en) | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US7517352B2 (en) | 2000-04-07 | 2009-04-14 | Bacchus Vascular, Inc. | Devices for percutaneous remote endarterectomy |
US6574513B1 (en) | 2000-10-03 | 2003-06-03 | Brainmaster Technologies, Inc. | EEG electrode assemblies |
CA2431405A1 (en) | 2000-12-11 | 2002-06-20 | By-Pass, Inc. | Method and apparatus for forming apertures in blood vessels |
US8509913B2 (en) | 2001-04-13 | 2013-08-13 | Greatbatch Ltd. | Switched diverter circuits for minimizing heating of an implanted lead and/or providing EMI protection in a high power electromagnetic field environment |
US8075558B2 (en) | 2002-04-30 | 2011-12-13 | Surgrx, Inc. | Electrosurgical instrument and method |
US6733499B2 (en) * | 2002-02-28 | 2004-05-11 | Biosense Webster, Inc. | Catheter having circular ablation assembly |
US6974467B1 (en) | 2002-11-04 | 2005-12-13 | Gonzales Jr Antonio | Method and apparatus for making a precise surgical incision |
US20040122349A1 (en) | 2002-12-20 | 2004-06-24 | Lafontaine Daniel M. | Closure device with textured surface |
US6847848B2 (en) | 2003-01-07 | 2005-01-25 | Mmtc, Inc | Inflatable balloon catheter structural designs and methods for treating diseased tissue of a patient |
US20040147917A1 (en) | 2003-01-23 | 2004-07-29 | Mueller Richard L. | Device and method for treatment of breast tissue with electromagnetic radiation |
US8021362B2 (en) | 2003-03-27 | 2011-09-20 | Terumo Kabushiki Kaisha | Methods and apparatus for closing a layered tissue defect |
US7811303B2 (en) | 2003-08-26 | 2010-10-12 | Medicine Lodge Inc | Bodily tissue dilation systems and methods |
US20050113854A1 (en) | 2003-11-25 | 2005-05-26 | Uckele John E. | Cervical conization device |
US20050165427A1 (en) | 2004-01-22 | 2005-07-28 | Jahns Scott E. | Vessel sealing devices |
EP1715792A2 (en) | 2004-01-30 | 2006-11-02 | NMT Medical, Inc. | Welding systems for closure of cardiac openings |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
ES2308505T3 (en) | 2004-05-14 | 2008-12-01 | Medtronic, Inc. | ULTRASONIC ENERGY USE SYSTEM FOCUSED ON HIGH INTENS IDAD TO FORM A CUTTED FABRIC AREA. |
US8241315B2 (en) | 2004-06-24 | 2012-08-14 | Boston Scientific Scimed, Inc. | Apparatus and method for treating occluded vasculature |
US7766891B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
EP3505138A1 (en) | 2004-10-02 | 2019-07-03 | Edwards Lifesciences CardiAQ LLC | Prosthetic aortic heart valve |
EP1871245A4 (en) | 2005-04-05 | 2010-10-27 | Interventional Spine Inc | Tissue dilation systems and related methods |
KR100634546B1 (en) | 2005-06-30 | 2006-10-13 | 삼성전자주식회사 | Electrode for measuring bio signal |
US8734362B2 (en) | 2005-07-26 | 2014-05-27 | Edward M. Boyle, JR. | Minimally invasive methods and apparatus |
US7628789B2 (en) | 2005-08-17 | 2009-12-08 | Pulmonx Corporation | Selective lung tissue ablation |
US20070156156A1 (en) | 2005-09-02 | 2007-07-05 | Madison Surgical Designs, Llc | Surgical devices and related methods thereof |
JP2007185495A (en) | 2006-01-13 | 2007-07-26 | Olympus Medical Systems Corp | Overtube |
US8585645B2 (en) | 2006-11-13 | 2013-11-19 | Uptake Medical Corp. | Treatment with high temperature vapor |
WO2008128186A1 (en) | 2007-04-12 | 2008-10-23 | Applied Medical Resources Corporation | Method and apparatus for tissue morcellation |
WO2008144522A2 (en) | 2007-05-17 | 2008-11-27 | Boston Scientific Scimed, Inc. | Tissue securing and sealing apparatus and related methods of use |
US8317771B2 (en) * | 2007-07-11 | 2012-11-27 | Apollo Endosurgery, Inc. | Methods and systems for performing submucosal medical procedures |
US8939991B2 (en) | 2008-06-08 | 2015-01-27 | Hotspur Technologies, Inc. | Apparatus and methods for removing obstructive material from body lumens |
WO2010001405A1 (en) | 2008-07-02 | 2010-01-07 | Angioslide Ltd. | Corrugated balloon catheter and methods of use thereof |
WO2010022060A1 (en) | 2008-08-19 | 2010-02-25 | Wilson-Cook Medical Inc. | Apparatus for removing lymph nodes or anchoring into tissue during a translumenal procedure |
US9408575B2 (en) | 2009-04-29 | 2016-08-09 | Bio-Signal Group Corp. | EEG kit |
CU20090172A6 (en) | 2009-10-09 | 2011-10-05 | Facultad De Quimica Universidad De La Habana | TRICYCLIC AND TETRACYCLIC SYSTEMS WITH ACTIVITY ON THE CENTRAL AND VASCULAR NERVOUS SYSTEM |
AU2010313429B2 (en) | 2009-10-30 | 2013-10-17 | Cook Medical Technologies Llc | System and method for performing a full thickness tissue biopsy |
US9949630B2 (en) | 2009-11-04 | 2018-04-24 | The Trustees Of The University Of Pennsylvania | Medical instrument system and method for manipulating target tissue |
US8239030B1 (en) | 2010-01-06 | 2012-08-07 | DJ Technologies | Transcranial stimulation device and method based on electrophysiological testing |
US20110190764A1 (en) * | 2010-01-29 | 2011-08-04 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US8632525B2 (en) | 2010-09-17 | 2014-01-21 | Ethicon Endo-Surgery, Inc. | Power control arrangements for surgical instruments and batteries |
US8695866B2 (en) | 2010-10-01 | 2014-04-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a power control circuit |
US10022179B2 (en) | 2010-12-14 | 2018-07-17 | Ethicon, Inc. | Bipolar medical devices for extracting tissue and methods therefor |
JP5999915B2 (en) | 2011-02-14 | 2016-09-28 | 株式会社アイ・メデックス | Biological electrodes used for biological information measurement and biological treatment, and electrode pads used therefor |
US8900161B2 (en) | 2011-04-01 | 2014-12-02 | Cook Medical Technologies Llc | Tissue sampling device and method |
US9283019B2 (en) | 2011-06-08 | 2016-03-15 | Warsaw Orthopedic, Inc. | Flexible guide wire |
US20130150701A1 (en) | 2011-11-08 | 2013-06-13 | Sara Budar | Multi-lumen thoracic catheter and uses thereof |
JP6441679B2 (en) | 2011-12-09 | 2018-12-19 | メタベンション インコーポレイテッド | Therapeutic neuromodulation of the liver system |
WO2013112343A1 (en) | 2012-01-24 | 2013-08-01 | St. Jude Medical Puerto Rico Llc | Procedural sheath securement device |
WO2013116240A1 (en) | 2012-01-30 | 2013-08-08 | Inneroptic Technology, Inc. | Multiple medical device guidance |
WO2013155557A1 (en) | 2012-04-16 | 2013-10-24 | The University Of Queensland | A microbiopsy device |
US9226767B2 (en) | 2012-06-29 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Closed feedback control for electrosurgical device |
JP6020908B2 (en) | 2012-12-06 | 2016-11-02 | 国立研究開発法人産業技術総合研究所 | Endoscopy tissue collection device |
US20140277071A1 (en) | 2013-03-12 | 2014-09-18 | Acclarent, Inc. | Features to enhance grip of balloon within airway |
US20140277039A1 (en) * | 2013-03-15 | 2014-09-18 | Acclarent, Inc. | Apparatus and method for treatment of ethmoid sinusitis |
US20140276687A1 (en) | 2013-03-15 | 2014-09-18 | Volcano Corporation | Assessment of varicose vein ablation via imaging or functional measurement analysis |
CN105530875B (en) | 2013-03-15 | 2018-06-01 | 波士顿科学国际有限公司 | Cutting tissue snare |
EP2986229A4 (en) | 2013-04-16 | 2016-09-28 | Transmed7 Llc | Methods, devices and therapeutic platform for automated, selectable, soft tissue resection |
WO2014194146A2 (en) | 2013-05-29 | 2014-12-04 | Chest Innovations | Devices and methods for obtaining tissue samples |
ES2928221T3 (en) | 2013-09-24 | 2022-11-16 | Adagio Medical Inc | Liquid-Based Near-Critical Endovascular Cryoablation Catheter |
US20160235431A1 (en) | 2013-09-27 | 2016-08-18 | Release Medical, Inc. | Tissue incision device and method |
US20150265331A1 (en) | 2014-03-18 | 2015-09-24 | Boston Scientific Scimed, Inc. | Devices for reducing lung volume and related methods of use |
EP3169263B1 (en) | 2014-08-18 | 2018-10-31 | G-Coder Systems AB | Arrangement for minimal invasive intervention |
US10661061B2 (en) | 2014-09-08 | 2020-05-26 | Sanovas Intellectual Property, Llc | Clearance of sinus ostia blockage |
WO2016205514A1 (en) * | 2015-06-17 | 2016-12-22 | Saphena Medical, Inc. | Unitary endoscopic vessel harvesting devices |
US10314578B2 (en) | 2015-09-29 | 2019-06-11 | Ethicon Llc | Battery drain circuit for surgical instrument |
DE102016101915A1 (en) | 2016-02-03 | 2017-08-03 | Aesculap Ag | Minimally invasive incision instrument with guided multiple cutting edge |
US10555769B2 (en) | 2016-02-22 | 2020-02-11 | Ethicon Llc | Flexible circuits for electrosurgical instrument |
ES2949144T3 (en) | 2016-11-23 | 2023-09-26 | Corit Medical Llc | Tissue reduction apparatus |
US10980570B2 (en) | 2017-01-12 | 2021-04-20 | Cardiac Pacemakers, Inc. | Implantation of an active medical device using the internal thoracic vasculature |
WO2018144898A1 (en) | 2017-02-02 | 2018-08-09 | Precision Thoracic, Llc | Minimally invasive methods apparatus for target-tissue excision |
CN118141450A (en) | 2017-05-25 | 2024-06-07 | 泰尔茂株式会社 | Adhesive closure system |
EP3717050A4 (en) | 2017-11-28 | 2021-08-04 | Pneumonix Medical, Inc. | Apparatus and method to seal a tissue tract |
US11026751B2 (en) | 2017-12-28 | 2021-06-08 | Cilag Gmbh International | Display of alignment of staple cartridge to prior linear staple line |
JP7391852B2 (en) | 2017-12-28 | 2023-12-05 | エシコン エルエルシー | Detecting the appearance of end effectors in liquids |
CN112367935A (en) | 2018-06-13 | 2021-02-12 | 赫拉库雷医疗有限公司 | Selective ablation and detection of tissue mass |
CN112839604B (en) | 2018-07-02 | 2023-07-18 | 柯惠有限合伙公司 | 3D printing and custom antenna navigation for ablating tissue |
US11723708B2 (en) | 2018-07-31 | 2023-08-15 | Prana Thoracic, Inc. | Method for removing a tissue lesion |
US20200038089A1 (en) | 2018-07-31 | 2020-02-06 | Ethicon, Inc. | Tissue resection apparatus |
US20200038097A1 (en) * | 2018-07-31 | 2020-02-06 | Ethicon, Inc. | Kit for removing a tissue lesion |
US20210219967A1 (en) | 2019-07-16 | 2021-07-22 | Ethicon, Inc. | Systems, devices, and methods for coring tissue |
US11638606B2 (en) | 2020-04-15 | 2023-05-02 | Bard Peripheral Vascular, Inc. | Bipolar electrosurgical pleura sealing device, system, and method of operating same |
US20210338316A1 (en) | 2020-04-30 | 2021-11-04 | Ethicon, Inc. | Systems and methods for sealing cored or punctured tissue using inflatable balloon |
US20210338315A1 (en) | 2020-04-30 | 2021-11-04 | Ethicon, Inc. | Systems and methods for sealing cored or punctured tissue using fill material |
US20210338265A1 (en) | 2020-04-30 | 2021-11-04 | Ethicon, Inc. | Methods and devices for delivering cancer therapy to a target tissue site via a cored tissue cavity |
US20210338215A1 (en) | 2020-04-30 | 2021-11-04 | Ethicon, Inc. | Tissue resection systems and methods for diagnostic and therapeutic implementation |
US20210338218A1 (en) | 2020-04-30 | 2021-11-04 | Ethicon, Inc. | Systems and methods for sealing cored or punctured tissue |
EP4132388A1 (en) | 2020-04-30 | 2023-02-15 | Prana Thoracic, Inc. | Systems, devices, and methods for coring tissue |
US20210378731A1 (en) | 2020-06-08 | 2021-12-09 | Ethicon, Inc. | Tissue resection control systems and methods |
CN116490133A (en) | 2020-06-08 | 2023-07-25 | 普拉纳胸科公司 | Tissue ablation control system and method |
US20210393332A1 (en) | 2020-06-22 | 2021-12-23 | Ethicon, Inc. | Methods and devices for navigating a tissue resection device |
US20220031382A1 (en) | 2020-07-28 | 2022-02-03 | Ethicon, Inc. | Battery operated tissue coring device |
US20220047314A1 (en) | 2020-08-11 | 2022-02-17 | Ethicon, Inc. | Tissue dilation and resection systems and methods |
WO2022038433A1 (en) | 2020-08-17 | 2022-02-24 | Ethicon, Inc. | Coring and amputation devices, systems, and methods |
WO2022214896A1 (en) | 2021-04-09 | 2022-10-13 | Ethicon, Inc. | Systems, devices, and methods for coring tissue |
-
2019
- 2019-07-16 US US16/512,616 patent/US20200038089A1/en not_active Abandoned
- 2019-07-30 BR BR102019015646A patent/BR102019015646A2/en unknown
- 2019-07-30 EP EP19189128.2A patent/EP3603545B1/en active Active
- 2019-07-30 JP JP2019139478A patent/JP7481096B2/en active Active
- 2019-07-30 ES ES19189128T patent/ES2870804T3/en active Active
- 2019-07-30 PL PL19189128T patent/PL3603545T3/en unknown
- 2019-07-31 CN CN201910701397.XA patent/CN110772313A/en active Pending
-
2023
- 2023-06-15 US US18/335,975 patent/US12102372B2/en active Active
-
2024
- 2024-04-25 JP JP2024071473A patent/JP2024087050A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040254572A1 (en) * | 2003-04-25 | 2004-12-16 | Mcintyre Jon T. | Self anchoring radio frequency ablation array |
US20070179494A1 (en) * | 2003-05-16 | 2007-08-02 | Andre Faure | Medical device using a coiled electrode |
US20120071922A1 (en) * | 2010-09-20 | 2012-03-22 | Shanley John F | System for providing surgical access |
US9895190B2 (en) * | 2014-04-28 | 2018-02-20 | Warsaw Orthopedic, Inc. | Devices and methods for radiofrequency ablation having at least two electrodes |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12102372B2 (en) | 2018-07-31 | 2024-10-01 | Prana Thoracic, Inc. | Tissue resection apparatus |
US20210338265A1 (en) * | 2020-04-30 | 2021-11-04 | Ethicon, Inc. | Methods and devices for delivering cancer therapy to a target tissue site via a cored tissue cavity |
US20210393332A1 (en) * | 2020-06-22 | 2021-12-23 | Ethicon, Inc. | Methods and devices for navigating a tissue resection device |
WO2021260468A1 (en) * | 2020-06-22 | 2021-12-30 | Ethicon, Inc. | Devices for navigating a tissue resection device |
WO2022038433A1 (en) * | 2020-08-17 | 2022-02-24 | Ethicon, Inc. | Coring and amputation devices, systems, and methods |
Also Published As
Publication number | Publication date |
---|---|
ES2870804T3 (en) | 2021-10-27 |
US12102372B2 (en) | 2024-10-01 |
JP2024087050A (en) | 2024-06-28 |
EP3603545A1 (en) | 2020-02-05 |
BR102019015646A2 (en) | 2020-01-28 |
US20230380878A1 (en) | 2023-11-30 |
PL3603545T3 (en) | 2021-12-06 |
EP3603545B1 (en) | 2021-03-24 |
JP2020018852A (en) | 2020-02-06 |
JP7481096B2 (en) | 2024-05-10 |
CN110772313A (en) | 2020-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12102372B2 (en) | Tissue resection apparatus | |
US11723708B2 (en) | Method for removing a tissue lesion | |
EP3603546B1 (en) | A kit for removing a tissue lesion | |
US11103272B2 (en) | Minimally invasive methods and apparatus for target-tissue excision | |
US8734362B2 (en) | Minimally invasive methods and apparatus | |
US20210219967A1 (en) | Systems, devices, and methods for coring tissue | |
CA3177320A1 (en) | Systems, devices, and methods for coring tissue | |
US20220047322A1 (en) | Coring and amputation devices, systems, and methods | |
WO2022214896A1 (en) | Systems, devices, and methods for coring tissue | |
US20210338315A1 (en) | Systems and methods for sealing cored or punctured tissue using fill material | |
BR102019015643A2 (en) | method to remove a tissue injury | |
Tillson | Abdominal biopsy procedures: intestines and liver. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: ETHICON, INC., NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:COHN, WILLIAM;MELCHOR, JONATHAN;NGUYEN, STEVEN;SIGNING DATES FROM 20190716 TO 20200113;REEL/FRAME:051530/0253 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
AS | Assignment |
Owner name: PRANA THORACIC, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ETHICON, INC.;REEL/FRAME:061820/0056 Effective date: 20220630 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |